Feng Ni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Feng Ni has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Ping Xu
Bio-NMR and Protein Research Laboratory, Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec H4P 2R2, Canada
5 shared publicationsDmitri Tolkatchev
Biomolecular NMR and Protein Research Group, Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec, Canada
3 shared publicationsPing Wang
Bio-NMR and Protein Research Laboratory, Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec H4P 2R2, Canada
2 shared publicationsSurajit Bhattacharjya
Biomolecular NMR and Protein Research Laboratory, Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue, Montreal, Quebec, Canada
2 shared publicationsZhengding Su
Biomolecular NMR and Protein Research Group, Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec, Canada
2 shared publicationsAndrew Bateman
Endocrine Laboratory, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec H3G 1Y6, Canada
1 shared publication
Latest Publications
- 30 March 2010
- Published by Wiley
- p. 653-670
Recombinant Production of Intrinsically Disordered Proteins for Biophysical and Structural Characterization
- 30 March 2010
- Published by Wiley
- p. 653-670
Recombinant Production of Intrinsically Disordered Proteins for Biophysical and Structural Characterization
- 1 April 2008
- Published by Wiley in Protein Science
- Vol. 17 (4) , 711-724
Structure dissection of human progranulin identifies well‐folded granulin/epithelin modules with unique functional activities
Progranulin is a secreted protein with important functions in several physiological and pathological processes, such as embryonic development, host defense, and wound repair. Autosomal dominant mutations in the progranulin gene cause frontotemporal dementia, while overexpression of progranulin promotes the invasive progression of a range of tumors, including those of the breast and the brain. Structurally, progranulin consists of seven‐and‐a‐half tandem repeats of the granulin/epithelin module (GEM), several of which have been isolated as discrete 6‐kDa GEM peptides. We have expressed all seven human GEMs using recombinant DNA in Escherichia coli. High‐resolution NMR showed that only the three GEMs, hGrnA, hGrnC, and hGrnF, contain relatively well‐defined three‐dimensional structures in solution, while others are mainly mixtures of poorly structured disulfide isomers. The three‐dimensional structures of hGrnA, hGrnC, and hGrnF contain a stable stack of two β‐hairpins in their N‐terminal subdomains, but showed a more flexible C‐terminal subdomain. Interestingly, of the well‐structured GEMs, hGrnA demonstrated potent growth inhibition of a breast cancer cell line, while hGrnF was stimulatory. Poorly folded peptides were either weakly inhibitory or without activity. The functionally active and structurally well‐characterized human hGrnA offers a unique opportunity for detailed structure–function studies of these important GEM proteins as novel members of mammalian growth factors.
- 1 April 2008
- Published by Wiley in Protein Science
- Vol. 17 (4) , 711-724
Structure dissection of human progranulin identifies well‐folded granulin/epithelin modules with unique functional activities
Progranulin is a secreted protein with important functions in several physiological and pathological processes, such as embryonic development, host defense, and wound repair. Autosomal dominant mutations in the progranulin gene cause frontotemporal dementia, while overexpression of progranulin promotes the invasive progression of a range of tumors, including those of the breast and the brain. Structurally, progranulin consists of seven‐and‐a‐half tandem repeats of the granulin/epithelin module (GEM), several of which have been isolated as discrete 6‐kDa GEM peptides. We have expressed all seven human GEMs using recombinant DNA in Escherichia coli. High‐resolution NMR showed that only the three GEMs, hGrnA, hGrnC, and hGrnF, contain relatively well‐defined three‐dimensional structures in solution, while others are mainly mixtures of poorly structured disulfide isomers. The three‐dimensional structures of hGrnA, hGrnC, and hGrnF contain a stable stack of two β‐hairpins in their N‐terminal subdomains, but showed a more flexible C‐terminal subdomain. Interestingly, of the well‐structured GEMs, hGrnA demonstrated potent growth inhibition of a breast cancer cell line, while hGrnF was stimulatory. Poorly folded peptides were either weakly inhibitory or without activity. The functionally active and structurally well‐characterized human hGrnA offers a unique opportunity for detailed structure–function studies of these important GEM proteins as novel members of mammalian growth factors.
- 3 May 2007
- Published by Wiley in Biopolymers
- Vol. 86 (4) , 329-344
Conformational analyses of a partially-folded bioactive prodomain of human furin
- 3 May 2007
- Published by Wiley in Biopolymers
- Vol. 86 (4) , 329-344
Conformational analyses of a partially-folded bioactive prodomain of human furin
- 1 October 2006
- Published by Wiley in Protein Science
- Vol. 15 (10) , 2381-2394
Three‐dimensional structure and ligand interactions of the low molecular weight protein tyrosine phosphatase from Campylobacter jejuni
A putative low molecular weight protein tyrosine phosphatase (LMW‐PTP) was identified in the genome sequence of the bacterial pathogen, Campylobacter jejuni. This novel gene, cj1258, has sequence homology with a distinctive class of phosphatases widely distributed among prokaryotes and eukaryotes. We report here the solution structure of Cj1258 established by high‐resolution NMR spectroscopy using NOE‐derived distance restraints, hydrogen bond data, and torsion angle restraints. The three‐dimensional structure consists of a central four‐stranded parallel β‐sheet flanked by five α‐helices, revealing an overall structural topology similar to those of the eukaryotic LMW‐PTPs, such as human HCPTP‐A, bovine BPTP, and Saccharomyces cerevisiae LTP1, and to those of the bacterial LMW‐PTPs MPtpA from Mycobacterium tuberculosis and YwlE from Bacillus subtilis. The active site of the enzyme is flexible in solution and readily adapts to the binding of ligands, such as the phosphate ion. An NMR‐based screen was carried out against a number of potential inhibitors and activators, including phosphonomethylphenylalanine, derivatives of the cinnamic acid, 2‐hydroxy‐5‐nitrobenzaldehyde, cinnamaldehyde, adenine, and hypoxanthine. Despite its bacterial origin, both the three‐dimensional structure and ligand‐binding properties of Cj1258 suggest that this novel phosphatase may have functional roles close to those of eukaryotic and mammalian tyrosine phosphatases. The three‐dimensional structure along with mapping of small‐molecule binding will be discussed in the context of developing high‐affinity inhibitors of this novel LMW‐PTP.
- 1 October 2006
- Published by Wiley in Protein Science
- Vol. 15 (10) , 2381-2394
Three‐dimensional structure and ligand interactions of the low molecular weight protein tyrosine phosphatase from Campylobacter jejuni
A putative low molecular weight protein tyrosine phosphatase (LMW‐PTP) was identified in the genome sequence of the bacterial pathogen, Campylobacter jejuni. This novel gene, cj1258, has sequence homology with a distinctive class of phosphatases widely distributed among prokaryotes and eukaryotes. We report here the solution structure of Cj1258 established by high‐resolution NMR spectroscopy using NOE‐derived distance restraints, hydrogen bond data, and torsion angle restraints. The three‐dimensional structure consists of a central four‐stranded parallel β‐sheet flanked by five α‐helices, revealing an overall structural topology similar to those of the eukaryotic LMW‐PTPs, such as human HCPTP‐A, bovine BPTP, and Saccharomyces cerevisiae LTP1, and to those of the bacterial LMW‐PTPs MPtpA from Mycobacterium tuberculosis and YwlE from Bacillus subtilis. The active site of the enzyme is flexible in solution and readily adapts to the binding of ligands, such as the phosphate ion. An NMR‐based screen was carried out against a number of potential inhibitors and activators, including phosphonomethylphenylalanine, derivatives of the cinnamic acid, 2‐hydroxy‐5‐nitrobenzaldehyde, cinnamaldehyde, adenine, and hypoxanthine. Despite its bacterial origin, both the three‐dimensional structure and ligand‐binding properties of Cj1258 suggest that this novel phosphatase may have functional roles close to those of eukaryotic and mammalian tyrosine phosphatases. The three‐dimensional structure along with mapping of small‐molecule binding will be discussed in the context of developing high‐affinity inhibitors of this novel LMW‐PTP.
- 1 March 2005
- Published by Wiley in Protein Science
- Vol. 14 (3) , 828-835
Polymerization of the SAM domain of MAPKKK Ste11 from the budding yeast: Implications for efficient signaling through the MAPK cascades
The sterile alpha-motif (SAM) is a protein module approximately 70 residues long and mainly involved in the protein-protein interactions of cell signaling and transcriptional repression. The SAM domain of the yeast MAPKKK Ste11 has a well-folded dimeric structure in solution. Interestingly, the well-folded dimer of the Ste11 SAM undergoes a time-dependent self-assembly upon lowering of the pH, leading to the formation of high molecular weight oligomers. The oligomeric structures rapidly disassemble to the well-folded dimer upon reversal of the pH to close to neutral conditions. Circular dichroism (CD) and atomic force microscopy (AFM) experiments demonstrate that the oligomeric structure formed at pH 5.0 appears to be highly helical and has architecture akin to proto-fibrils. Residue-specific kinetics of pH-triggered oligomerization obtained from real-time 15N-1H HSQC experiments indicate that the dimer-oligomer transition appears to involve all residues of the well-folded dimeric structure of the Ste11 SAM. Very interestingly, the interactions of the Ste11 and Ste50 SAM domains also lead to the formation of non-homogeneous hetero-complexes with significant populations of high molecular weight aggregates. AFM imaging shows that the Ste11-Ste50 hetero-polymeric aggregates assume the shapes of circular nano-particles with dimensions of 50-60 nano-meters (nm), in contrast to the proto-fibrils formed by the Ste11 SAM domain alone. Such intrinsic propensity for dimer to oligomer transition of the Ste50-binding SAM domain of Ste11 may endow the MAPKKK Ste11 with unique functional properties required for efficient and high fidelity signal transduction in the budding yeast.
- 1 March 2005
- Published by Wiley in Protein Science
- Vol. 14 (3) , 828-835
Polymerization of the SAM domain of MAPKKK Ste11 from the budding yeast: Implications for efficient signaling through the MAPK cascades
The sterile alpha-motif (SAM) is a protein module approximately 70 residues long and mainly involved in the protein-protein interactions of cell signaling and transcriptional repression. The SAM domain of the yeast MAPKKK Ste11 has a well-folded dimeric structure in solution. Interestingly, the well-folded dimer of the Ste11 SAM undergoes a time-dependent self-assembly upon lowering of the pH, leading to the formation of high molecular weight oligomers. The oligomeric structures rapidly disassemble to the well-folded dimer upon reversal of the pH to close to neutral conditions. Circular dichroism (CD) and atomic force microscopy (AFM) experiments demonstrate that the oligomeric structure formed at pH 5.0 appears to be highly helical and has architecture akin to proto-fibrils. Residue-specific kinetics of pH-triggered oligomerization obtained from real-time 15N-1H HSQC experiments indicate that the dimer-oligomer transition appears to involve all residues of the well-folded dimeric structure of the Ste11 SAM. Very interestingly, the interactions of the Ste11 and Ste50 SAM domains also lead to the formation of non-homogeneous hetero-complexes with significant populations of high molecular weight aggregates. AFM imaging shows that the Ste11-Ste50 hetero-polymeric aggregates assume the shapes of circular nano-particles with dimensions of 50-60 nano-meters (nm), in contrast to the proto-fibrils formed by the Ste11 SAM domain alone. Such intrinsic propensity for dimer to oligomer transition of the Ste50-binding SAM domain of Ste11 may endow the MAPKKK Ste11 with unique functional properties required for efficient and high fidelity signal transduction in the budding yeast.
- Open Access
- 13 April 2004
- Published by Wiley in European Journal of Biochemistry
- Vol. 271 (9) , 1725-1736
Single phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high‐affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ‐RGS3 protein
The B class cell‐attached ephrins mediate contact‐dependent cell–cell communications and transduce the contact signals to the host cells through the binding interactions of their cytoplasmic domains. Two classes of intracellular effectors of B ephrins have been identified: one contains the PSD‐95/Dlg/ZO‐1 (PDZ) domain (for example PDZ‐RGS3), and the second the Src homology 2 (SH2) domain (e.g. the Grb4 adaptor protein). The interaction with Grb4 requires phosphorylation of tyrosine residues on the conserved cytoplasmic C‐terminal region of B ephrins, while binding to the PDZ domain is independent of tyrosine phosphorylation. However, the exact phosphorylation site(s) required for signaling remained obscure and it is also unknown whether the two classes of effectors can bind to B ephrins simultaneously or if the binding of one affects the binding of the other. We report here that phosphorylation of Tyr304 in the functional C‐terminal region (residues 301–333) of ephrin B2 confers high‐affinity binding to the SH2 domain of the Grb4 protein. Tyrosine phosphorylation at other candidate sites resulted in only minor change of the binding of Tyr304‐phosphorylated ephrin B peptide (i.e. ephrinB2(301–333)‐pY304) with the SH2 domain. 1H‐15N NMR HSQC experiments show that only the ephrinB2(301–333)‐pY304 peptide forms a stable and specific binding complex with the SH2 domain of Grb4. The SH2 and PDZ domains were found to bind to the Tyr304 phosphopeptide both independently and at the same time, forming a three‐component molecular complex. Taken together, our studies identify a novel SH2 domain binding motif, PHpY304EKV, on the cytoplasmic domains of B ephrins that may be essential for reverse signaling via the Grb4 adaptor protein alone or in concert with proteins containing PDZ domains.
- 13 April 2004
- Published by Wiley in European Journal of Biochemistry
- Vol. 271 (9) , 1725-1736
Open AccessSingle phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high‐affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ‐RGS3 protein
The B class cell‐attached ephrins mediate contact‐dependent cell–cell communications and transduce the contact signals to the host cells through the binding interactions of their cytoplasmic domains. Two classes of intracellular effectors of B ephrins have been identified: one contains the PSD‐95/Dlg/ZO‐1 (PDZ) domain (for example PDZ‐RGS3), and the second the Src homology 2 (SH2) domain (e.g. the Grb4 adaptor protein). The interaction with Grb4 requires phosphorylation of tyrosine residues on the conserved cytoplasmic C‐terminal region of B ephrins, while binding to the PDZ domain is independent of tyrosine phosphorylation. However, the exact phosphorylation site(s) required for signaling remained obscure and it is also unknown whether the two classes of effectors can bind to B ephrins simultaneously or if the binding of one affects the binding of the other. We report here that phosphorylation of Tyr304 in the functional C‐terminal region (residues 301–333) of ephrin B2 confers high‐affinity binding to the SH2 domain of the Grb4 protein. Tyrosine phosphorylation at other candidate sites resulted in only minor change of the binding of Tyr304‐phosphorylated ephrin B peptide (i.e. ephrinB2(301–333)‐pY304) with the SH2 domain. 1H‐15N NMR HSQC experiments show that only the ephrinB2(301–333)‐pY304 peptide forms a stable and specific binding complex with the SH2 domain of Grb4. The SH2 and PDZ domains were found to bind to the Tyr304 phosphopeptide both independently and at the same time, forming a three‐component molecular complex. Taken together, our studies identify a novel SH2 domain binding motif, PHpY304EKV, on the cytoplasmic domains of B ephrins that may be essential for reverse signaling via the Grb4 adaptor protein alone or in concert with proteins containing PDZ domains.
- Open Access
- 1 February 1996
- Published by Wiley in Protein Science
- Vol. 5 (2) , 195-203
Structural resiliency of an EGF‐like subdomain bound to its target protein, thrombin
The thrombin‐bound structures of native peptide fragments from the fifth EGF‐like domain of thrombomodulin were determined by use of NMR and transferred NOE spectroscopy. The bound peptides assume an EGF‐like structure of an antiparallel β‐sheet, a novel structural motif observed for a bound peptide in protein‐peptide complexes. There is a remarkable structural resiliency of this structure motif manifested in its ability to accommodate a different number of residues within the disulfide loop. Docking experiments revealed that the key contacts with thrombin are hydrophobic interactions between the side chains of residues Ile 414 and Ile 424 of thrombomodulin and a hydrophobic pocket on the thrombin surface. Residues Leu 415, Phe 419, and Ile 420, which would have been buried in intact EGF‐like domains, are unfavorably exposed in the complex of thrombin with the EGF‐like thrombomodulin fragment, thus providing a rationale for the enhancement of binding affinity upon the deletion of Ile 420. The unique β‐sheet structures of the bound peptides are specified by the presence of disulfide bridges in the peptides because a corresponding linear thrombomodulin fragment folds into a sheet structure with a different backbone topology. The different bound conformations for the linear and the cyclized peptides indicate that side‐chain interactions within a specific environment may dictate the folding of bound peptides in protein‐peptide complexes.
- 1 February 1996
- Published by Wiley in Protein Science
- Vol. 5 (2) , 195-203
Open AccessStructural resiliency of an EGF‐like subdomain bound to its target protein, thrombin
The thrombin‐bound structures of native peptide fragments from the fifth EGF‐like domain of thrombomodulin were determined by use of NMR and transferred NOE spectroscopy. The bound peptides assume an EGF‐like structure of an antiparallel β‐sheet, a novel structural motif observed for a bound peptide in protein‐peptide complexes. There is a remarkable structural resiliency of this structure motif manifested in its ability to accommodate a different number of residues within the disulfide loop. Docking experiments revealed that the key contacts with thrombin are hydrophobic interactions between the side chains of residues Ile 414 and Ile 424 of thrombomodulin and a hydrophobic pocket on the thrombin surface. Residues Leu 415, Phe 419, and Ile 420, which would have been buried in intact EGF‐like domains, are unfavorably exposed in the complex of thrombin with the EGF‐like thrombomodulin fragment, thus providing a rationale for the enhancement of binding affinity upon the deletion of Ile 420. The unique β‐sheet structures of the bound peptides are specified by the presence of disulfide bridges in the peptides because a corresponding linear thrombomodulin fragment folds into a sheet structure with a different backbone topology. The different bound conformations for the linear and the cyclized peptides indicate that side‐chain interactions within a specific environment may dictate the folding of bound peptides in protein‐peptide complexes.